skip to Main Content

August 2018

This month's articles focus on pharmacotherapy for two common diseases in Cardiology and Nephrology: Heart Failure with Reduced Ejection Fraction (HFrEF) and Diabetic Nephropathy. COMET: Comparing beta-blocker to beta-blocker RENAAL: Addition of Angiotensin II receptor blockers (ARB) to antihypertensive therapy

Read more
Feb 01 2018

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

EBM, Landmark Research

Antagonists of the P2Y12 ADP receptor, in addition to aspirin, are the mainstay of treatment of non-ST elevation acute coronary syndromes (NSTE-ACS).  Although Clopidogrel (Plavix®) has been widely used for years, newer agents have come into use, including Ticagrelor (Brilinta®) and Prasugrel…

Read more
Back To Top
Login
Log in below to access learning modules.
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.